Shorter TB treatment may help kidney transplant patients
NCT ID NCT05411744
First seen Jan 24, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tests a one-month treatment for latent tuberculosis (TB) in people waiting for a kidney transplant. The goal is to see if the treatment is safe and easy to complete. 25 adults with end-stage kidney disease and latent TB will take the medication and be monitored for side effects and compliance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pinki J Bhatt
New Brunswick, New Jersey, 08901, United States
Conditions
Explore the condition pages connected to this study.